{
  "protocolId": "SPOTLIGHT (ISN 8951-CL-0301, Phase 3)",
  "version": "2.0",
  "generatedAt": "2026-02-13T14:39:39.401768",
  "atomicCriteria": [
    {
      "atomicId": "A0001",
      "originalCriterionId": "INC_1",
      "criterionType": "inclusion",
      "atomicText": "IRB/IEC approved written informed consent and privacy language obtained from subject or legally authorized representative",
      "normalizedText": "IRB/IEC approved written informed consent and privacy language obtained from subject or legally authorized representative",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_1_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 1
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "Inclusion/Exclusion Criteria:\nInclusion Criteria: \nWaivers to the inclusion criteria will NOT be allowed.\nGeneral Criteria:\n1. Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written \ninformed consent and privacy language as per national regulations (e.g., Health Insurance \nPortability and Accountability Act [HIPAA] Authorization for US sites) must be obtained from \nthe subject or legally authorized representative (if applicable) prior to any study-related \nproced...",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0002",
      "originalCriterionId": "INC_2",
      "criterionType": "inclusion",
      "atomicText": "Age >= 18 years at the time of signing informed consent",
      "normalizedText": "Age >= 18 years at the time of signing informed consent",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          4265453
        ],
        "conceptNames": [
          "Age"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "397669002"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 18"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "30525-0",
            "display": "Age"
          }
        ],
        "searchParams": "code=http://loinc.org|30525-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_2_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 2
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "the subject or legally authorized representative (if applicable) prior to any study-related \nprocedures.\n2. Subject is considered an adult (e.g., \u2265 18 years of age in the US) according to local regulation\nat the time of signing the informed consent.\n3. Subject agrees not to participate in another interventional study while on study treatment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0003",
      "originalCriterionId": "INC_3",
      "criterionType": "inclusion",
      "atomicText": "Participation in another interventional study",
      "normalizedText": "Participation in another interventional study",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_3_1a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 3
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "at the time of signing the informed consent.\n3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0004",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "atomicText": "Positive serum pregnancy test",
      "normalizedText": "Positive serum pregnancy test",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_4_1a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 4
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "pregnancy_status",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0005",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "atomicText": "Positive serum pregnancy test",
      "normalizedText": "Positive serum pregnancy test",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_4_1b1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 5
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "pregnancy_status",
      "expressionNodeId": "1b1"
    },
    {
      "atomicId": "A0006",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "atomicText": "Demonstrated non-pregnant status through additional testing",
      "normalizedText": "Demonstrated non-pregnant status through additional testing",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_4_1b2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 6
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "pregnancy_status",
      "expressionNodeId": "1b2"
    },
    {
      "atomicId": "A0007",
      "originalCriterionId": "INC_4",
      "criterionType": "inclusion",
      "atomicText": "At least one of the other specified conditions applies",
      "normalizedText": "At least one of the other specified conditions applies",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_4_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 7
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "3. Subject agrees not to participate in another interventional study while on study treatment.\n4. A female subject is eligible to participate if she is not pregnant (negative serum pregnancy test \nat Screening; female subjects with elevated serum beta human chorionic gonadotropin (\u03b2hCG) \nand a demonstrated non-pregnant status through additional testing are eligible) and at least 1 of \nthe following conditions applies:\na. Not a woman of childbearing potential (WOCBP) as defined in Appendix 12.3",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0008",
      "originalCriterionId": "INC_5",
      "criterionType": "inclusion",
      "atomicText": "Female",
      "normalizedText": "Female",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5_1",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 8
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "the final administration of oxaliplatin and 6 months after the final administration of all \nother study drugs.\n5. Female subject must agree not to breastfeed starting at Screening and throughout the study \nperiod, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other stu...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0009",
      "originalCriterionId": "INC_5",
      "criterionType": "inclusion",
      "atomicText": "Agrees not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration",
      "normalizedText": "Agrees not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5_2",
        "groupLogic": "IMPLICATION_REQUIREMENT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 9
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "the final administration of oxaliplatin and 6 months after the final administration of all \nother study drugs.\n5. Female subject must agree not to breastfeed starting at Screening and throughout the study \nperiod, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other stu...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0010",
      "originalCriterionId": "INC_6",
      "criterionType": "inclusion",
      "atomicText": "Female subject",
      "normalizedText": "Female subject",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female subject\n-- Requires manual SQL generation",
        "sqlExecutable": false,
        "valueConstraint": "gender_concept_id = 8532"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_6_1",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 10
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0011",
      "originalCriterionId": "INC_6",
      "criterionType": "inclusion",
      "atomicText": "Donate ova",
      "normalizedText": "Donate ova",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_6_2a1a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 11
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "ova_donation",
      "expressionNodeId": "2a1a"
    },
    {
      "atomicId": "A0012",
      "originalCriterionId": "INC_6",
      "criterionType": "inclusion",
      "atomicText": "Donate ova",
      "normalizedText": "Donate ova",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_6_2a2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 12
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "ova_donation",
      "expressionNodeId": "2a2a"
    },
    {
      "atomicId": "A0013",
      "originalCriterionId": "INC_6",
      "criterionType": "inclusion",
      "atomicText": "Donate ova",
      "normalizedText": "Donate ova",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 51.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_6_2a3a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 13
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "period, and for 6 months after the final study treatment administration.\n6. Female subject must not donate ova starting at Screening and throughout the study period, and \nfor 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe trea...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "ova_donation",
      "expressionNodeId": "2a3a"
    },
    {
      "atomicId": "A0014",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "atomicText": "Male subject",
      "normalizedText": "Male subject",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Male subject\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_7_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 14
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0015",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "atomicText": "Sexually active",
      "normalizedText": "Sexually active",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_7_1b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 15
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0016",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "atomicText": "Has female partner(s) of childbearing potential",
      "normalizedText": "Has female partner(s) of childbearing potential",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_7_1c",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 16
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1c"
    },
    {
      "atomicId": "A0017",
      "originalCriterionId": "INC_7",
      "criterionType": "inclusion",
      "atomicText": "Agrees to use a condom during the treatment period and for at least 6 months after the final study drug administration",
      "normalizedText": "Agrees to use a condom during the treatment period and for at least 6 months after the final study drug administration",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600058216
        ],
        "conceptNames": [
          "Other Investigational Agent"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C156875"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C156875",
            "display": "Other Investigational Agent"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_7_2",
        "groupLogic": "IMPLICATION_REQUIREMENT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 17
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "for 9 months after the final administration of oxaliplatin and 6 months after the final \nadministration of all other study drugs.\n7. A sexually active male subject with female partner(s) who are of childbearing potential must \nagree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study per...",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0018",
      "originalCriterionId": "INC_8",
      "criterionType": "inclusion",
      "atomicText": "Sex is Male",
      "normalizedText": "Sex is Male",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Sex is Male\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_8_1",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 18
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "agree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study period and \nfor 6 months after the final study drug administration.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0019",
      "originalCriterionId": "INC_8",
      "criterionType": "inclusion",
      "atomicText": "Sperm donation",
      "normalizedText": "Sperm donation",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_8_2a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 19
      },
      "provenance": {
        "pageNumber": 24,
        "textSnippet": "agree to use contraception as detailed in Appendix 12.3 Contraception Requirements during \nthe treatment period and for at least 6 months after the final study drug administration. \n8. Male subject must not donate sperm starting at Screening and throughout the study period and \nfor 6 months after the final study drug administration.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2a1"
    },
    {
      "atomicId": "A0020",
      "originalCriterionId": "INC_9",
      "criterionType": "inclusion",
      "atomicText": "Subject is male",
      "normalizedText": "Subject is male",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Subject is male\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_9_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 20
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0021",
      "originalCriterionId": "INC_9",
      "criterionType": "inclusion",
      "atomicText": "Partner is pregnant",
      "normalizedText": "Partner is pregnant",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_9_1b1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 21
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "partner_status",
      "expressionNodeId": "1b1"
    },
    {
      "atomicId": "A0022",
      "originalCriterionId": "INC_9",
      "criterionType": "inclusion",
      "atomicText": "Partner is breastfeeding",
      "normalizedText": "Partner is breastfeeding",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_9_1b2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 22
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "partner_status",
      "expressionNodeId": "1b2"
    },
    {
      "atomicId": "A0023",
      "originalCriterionId": "INC_9",
      "criterionType": "inclusion",
      "atomicText": "Agrees to remain abstinent for the required duration",
      "normalizedText": "Agrees to remain abstinent for the required duration",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_9_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 23
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "screening_only",
      "clinicalConceptGroup": "contraception_agreement",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0024",
      "originalCriterionId": "INC_9",
      "criterionType": "inclusion",
      "atomicText": "Agrees to use a condom for the required duration",
      "normalizedText": "Agrees to use a condom for the required duration",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_9_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 24
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "9. Male subject with a pregnant or breastfeeding partner(s) must agree to remain abstinent \nor use a condom for the duration of the pregnancy or for the time partner is \nbreastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days p...",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "screening_only",
      "clinicalConceptGroup": "contraception_agreement",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0025",
      "originalCriterionId": "INC_10",
      "criterionType": "inclusion",
      "atomicText": "Histologically confirmed diagnosis",
      "normalizedText": "Histologically confirmed diagnosis",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_10_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 25
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "breastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0026",
      "originalCriterionId": "INC_10",
      "criterionType": "inclusion",
      "atomicText": "Gastric adenocarcinoma",
      "normalizedText": "Gastric adenocarcinoma",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          196044
        ],
        "conceptNames": [
          "Primary malignant neoplasm of stomach"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "372014001"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "372014001",
            "display": "Primary malignant neoplasm of stomach"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C16.9",
            "display": "Malignant neoplasm of stomach, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|372014001,C16.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_10_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 26
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "breastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_or_gej_adenocarcinoma",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0027",
      "originalCriterionId": "INC_10",
      "criterionType": "inclusion",
      "atomicText": "Gastroesophageal junction (GEJ) adenocarcinoma",
      "normalizedText": "Gastroesophageal junction (GEJ) adenocarcinoma",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_10_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 27
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "breastfeeding throughout the study period and for 6 months after the final study drug \nadministration. \nDisease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_or_gej_adenocarcinoma",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0028",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Disease is radiologically confirmed",
      "normalizedText": "Disease is radiologically confirmed",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND o.observation_date >= @reference_date - INTERVAL '28 days'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_11_1a1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 28
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0029",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Locally advanced unresectable disease",
      "normalizedText": "Locally advanced unresectable disease",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          37165616
        ],
        "conceptNames": [
          "Locally advanced malignant neoplasm"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1255249000"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1255249000",
            "display": "Locally advanced malignant neoplasm"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1255249000",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_1a2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 29
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "advanced_unresectable_or_metastatic_disease",
      "expressionNodeId": "1a2a"
    },
    {
      "atomicId": "A0030",
      "originalCriterionId": "INC_11",
      "criterionType": "inclusion",
      "atomicText": "Metastatic disease",
      "normalizedText": "Metastatic disease",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          432851
        ],
        "conceptNames": [
          "Metastatic malignant neoplasm"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "128462008"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (432851)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "128462008",
            "display": "Metastatic malignant neoplasm"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|128462008",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_11_1a2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 30
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "Disease Specific Criteria:\n10. Subject has histologically confirmed diagnosis of Gastric or GEJ adenocarcinoma. \n11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "advanced_unresectable_or_metastatic_disease",
      "expressionNodeId": "1a2b"
    },
    {
      "atomicId": "A0031",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment",
      "normalizedText": "Radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 10.0,
        "impactScore": 0.1,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_12_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 31
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0032",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "Subject has only 1 evaluable lesion",
      "normalizedText": "Subject has only 1 evaluable lesion",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 10.0,
        "impactScore": 0.1,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_12_2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 32
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0033",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "History of radiotherapy",
      "normalizedText": "History of radiotherapy",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 10.0,
        "impactScore": 0.1,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND po.procedure_date >= @reference_date - INTERVAL '3 months'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_12_2b1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 33
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2b1"
    },
    {
      "atomicId": "A0034",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "The evaluable lesion is outside the field of prior radiotherapy",
      "normalizedText": "The evaluable lesion is outside the field of prior radiotherapy",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 10.0,
        "impactScore": 0.1,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          600054592
        ],
        "conceptNames": [
          "Radiation Therapy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C15313"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C15313",
            "display": "Radiation Therapy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_2c",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 34
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2c"
    },
    {
      "atomicId": "A0035",
      "originalCriterionId": "INC_12",
      "criterionType": "inclusion",
      "atomicText": "The evaluable lesion has documented progression following radiation therapy",
      "normalizedText": "The evaluable lesion has documented progression following radiation therapy",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 10.0,
        "impactScore": 0.1,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          600054592
        ],
        "conceptNames": [
          "Radiation Therapy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C15313"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id = 600054592",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C15313",
            "display": "Radiation Therapy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C15313",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_12_2d",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 35
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "11. Subject has radiologically confirmed locally advanced unresectable or metastatic disease within \n28 days prior to randomization. \n12. Subject has radiologically evaluable disease (measurable and/or non-measurable disease \naccording to RECIST 1.1), per local assessment, \u2264 28 days prior to randomization. For subjects \nwith only 1 evaluable lesion and prior radiotherapy \u2264 3 months before randomization, the lesion \nmust either be outside the field of prior radiotherapy or have documented prog...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2d"
    },
    {
      "atomicId": "A0036",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "atomicText": "Tumor expresses CLDN18.2",
      "normalizedText": "Tumor expresses CLDN18.2",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "Positive"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_13_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 36
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "biomarker",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "cldn18_2_status",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0037",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "atomicText": "CLDN18.2 expression in >= 75% of tumor cells",
      "normalizedText": "CLDN18.2 expression in >= 75% of tumor cells",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND m.value_as_number >= 75",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number >= 75"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_13_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 37
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "biomarker",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "cldn18_2_status",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0038",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "atomicText": "CLDN18.2 demonstrates moderate to strong membranous staining",
      "normalizedText": "CLDN18.2 demonstrates moderate to strong membranous staining",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "staining intensity in ['moderate', 'strong'] and location is 'membranous'"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_13_3",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 38
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "biomarker",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "cldn18_2_status",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0039",
      "originalCriterionId": "INC_13",
      "criterionType": "inclusion",
      "atomicText": "CLDN18.2 status determined by central IHC testing",
      "normalizedText": "CLDN18.2 status determined by central IHC testing",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_13_4",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 39
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "must either be outside the field of prior radiotherapy or have documented progression following \nradiation therapy.\n13. Subject\u2019s tumor expresses CLDN18.2 in \u2265 75% of tumor cells demonstrating moderate to strong \nmembranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "cldn18_2_status",
      "expressionNodeId": "4"
    },
    {
      "atomicId": "A0040",
      "originalCriterionId": "INC_14",
      "criterionType": "inclusion",
      "atomicText": "HER2-negative tumor status",
      "normalizedText": "HER2-negative tumor status",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3019066
        ],
        "conceptNames": [
          "HER2 Ag [Presence] in Tissue by Immune stain"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "18474-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3019066) AND Result is 'Negative' or equivalent concept for HER2 test",
        "sqlExecutable": true,
        "valueConstraint": "Result is 'Negative' or equivalent concept for HER2 test"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "62862-8",
            "display": "ERBB2 gene amplification analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|62862-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_14_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 40
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "biomarker",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "her2_status",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0041",
      "originalCriterionId": "INC_14",
      "criterionType": "inclusion",
      "atomicText": "Gastric tumor",
      "normalizedText": "Gastric tumor",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_14_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 41
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "primary_tumor_location",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0042",
      "originalCriterionId": "INC_14",
      "criterionType": "inclusion",
      "atomicText": "Gastroesophageal junction (GEJ) tumor",
      "normalizedText": "Gastroesophageal junction (GEJ) tumor",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_14_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 42
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "primary_tumor_location",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0043",
      "originalCriterionId": "INC_14",
      "criterionType": "inclusion",
      "atomicText": "HER2 status determined on a tumor specimen by local or central testing",
      "normalizedText": "HER2 status determined on a tumor specimen by local or central testing",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3019066
        ],
        "conceptNames": [
          "HER2 Ag [Presence] in Tissue by Immune stain"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "18474-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3019066)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "62862-8",
            "display": "ERBB2 gene amplification analysis"
          }
        ],
        "searchParams": "code=http://loinc.org|62862-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_14_3",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 43
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "membranous staining as determined by central IHC testing.\n14. Subject has a HER2-negative tumor as determined by local or central testing on a gastric or \nGEJ tumor specimen. (Unique to China: Subject has a known HER2-negative gastric or GEJ \ntumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0044",
      "originalCriterionId": "INC_15",
      "criterionType": "inclusion",
      "atomicText": "ECOG performance status 0-1",
      "normalizedText": "ECOG performance status 0-1",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          36305384
        ],
        "conceptNames": [
          "ECOG Performance Status score"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "89247-1"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND value_as_number >= 0 AND value_as_number <= 1",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 0 AND value_as_number <= 1"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score"
          }
        ],
        "searchParams": "code=http://loinc.org|89247-1",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_15_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 44
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "tumor).\nPhysical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibil...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "performance_status",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0045",
      "originalCriterionId": "INC_16",
      "criterionType": "inclusion",
      "atomicText": "Predicted life expectancy \u2265 12 weeks in the opinion of the investigator",
      "normalizedText": "Predicted life expectancy \u2265 12 weeks in the opinion of the investigator",
      "category": "performance_status",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          3050013
        ],
        "conceptNames": [
          "Life expectancy [OASIS]"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "46525-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (3050013) AND value_as_number >= 12",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 12"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "46525-2",
            "display": "Life expectancy [OASIS]"
          }
        ],
        "searchParams": "code=http://loinc.org|46525-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_16_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 45
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "Physical or Laboratory Findings\n15. Subject has ECOG performance status 0 to 1.\n16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibility. \na....",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "performance_status",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0046",
      "originalCriterionId": "INC_17",
      "criterionType": "inclusion",
      "atomicText": "Required laboratory tests for eligibility assessment collected",
      "normalizedText": "Required laboratory tests for eligibility assessment collected",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_17_root_a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 46
      },
      "provenance": {
        "pageNumber": 25,
        "textSnippet": "16. Subject has predicted life expectancy \uf0b3 12 weeks in the opinion of the investigator.\n17. Subject must meet all of the following criteria based on the centrally or locally analyzed \nlaboratory tests collected within 14 days prior to randomization. In the case of multiple sample \ncollections within this period, the most recent sample collection with available results should \nbe used to determine eligibility. \na. Hemoglobin (Hgb) \u2265 9 g/dL. Subjects requiring transfusions are eligible if they...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "root_a"
    },
    {
      "atomicId": "A0047",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma",
      "normalizedText": "Received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 40.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          37165616
        ],
        "conceptNames": [
          "Locally advanced malignant neoplasm"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1255249000"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1255249000",
            "display": "Locally advanced malignant neoplasm"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1255249000",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_1_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 47
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0048",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Received neo-adjuvant or adjuvant chemotherapy",
      "normalizedText": "Received neo-adjuvant or adjuvant chemotherapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 40.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_1_2a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 48
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "prior_systemic_therapy",
      "expressionNodeId": "2a1"
    },
    {
      "atomicId": "A0049",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Received immunotherapy",
      "normalizedText": "Received immunotherapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 40.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_1_2a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 49
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "prior_systemic_therapy",
      "expressionNodeId": "2a2"
    },
    {
      "atomicId": "A0050",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Received other systemic anticancer therapies",
      "normalizedText": "Received other systemic anticancer therapies",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 40.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_1_2a3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 50
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "prior_systemic_therapy",
      "expressionNodeId": "2a3"
    },
    {
      "atomicId": "A0051",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Completion of neo-adjuvant/adjuvant chemotherapy, immunotherapy, or other systemic anticancer therapy",
      "normalizedText": "Completion of neo-adjuvant/adjuvant chemotherapy, immunotherapy, or other systemic anticancer therapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 40.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_1_2b1a",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 51
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2b1a"
    },
    {
      "atomicId": "A0052",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Received treatment with herbal medications that have known antitumor activity",
      "normalizedText": "Received treatment with herbal medications that have known antitumor activity",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 40.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_1_3a",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 52
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "3a"
    },
    {
      "atomicId": "A0053",
      "originalCriterionId": "EXC_1",
      "criterionType": "exclusion",
      "atomicText": "Completion of treatment with herbal medications with known antitumor activity",
      "normalizedText": "Completion of treatment with herbal medications with known antitumor activity",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 40.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_1_3b1a",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 53
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "Exclusion Criteria:\nWaivers to the exclusion criteria will NOT be allowed. \nSubject who meets any of the following exclusion criteria prior to enrollment is not eligible for \nenrollment: \nProhibited Treatment or Therapies\n1. Subject has received prior systemic chemotherapy for locally advanced unresectable or \nmetastatic gastric or GEJ adenocarcinoma. However, subject may have received either neo adjuvant or adjuvant chemotherapy, immunotherapy or other systemic anticancer therapies as \nlong ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "3b1a"
    },
    {
      "atomicId": "A0054",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "atomicText": "Received radiotherapy",
      "normalizedText": "Received radiotherapy",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 10.0,
        "impactScore": 0.1,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_2_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 54
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0055",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "atomicText": "Diagnosis of gastric adenocarcinoma",
      "normalizedText": "Diagnosis of gastric adenocarcinoma",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          196044
        ],
        "conceptNames": [
          "Primary malignant neoplasm of stomach"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "372014001"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "372014001",
            "display": "Primary malignant neoplasm of stomach"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C16.9",
            "display": "Malignant neoplasm of stomach, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|372014001,C16.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_2_2a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 55
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_gej_adenocarcinoma",
      "expressionNodeId": "2a1"
    },
    {
      "atomicId": "A0056",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "atomicText": "Diagnosis of gastroesophageal junction (GEJ) adenocarcinoma",
      "normalizedText": "Diagnosis of gastroesophageal junction (GEJ) adenocarcinoma",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_2_2a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 56
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_gej_adenocarcinoma",
      "expressionNodeId": "2a2"
    },
    {
      "atomicId": "A0057",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "atomicText": "Disease is locally advanced unresectable",
      "normalizedText": "Disease is locally advanced unresectable",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          37165616
        ],
        "conceptNames": [
          "Locally advanced malignant neoplasm"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1255249000"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (37165616)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1255249000",
            "display": "Locally advanced malignant neoplasm"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1255249000",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_2_2b1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 57
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "disease_stage_unresectable_metastatic",
      "expressionNodeId": "2b1"
    },
    {
      "atomicId": "A0058",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "atomicText": "Disease is metastatic",
      "normalizedText": "Disease is metastatic",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 60.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_2_2b2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 58
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "disease_stage_unresectable_metastatic",
      "expressionNodeId": "2b2"
    },
    {
      "atomicId": "A0059",
      "originalCriterionId": "EXC_2",
      "criterionType": "exclusion",
      "atomicText": "Recovered from radiotherapy-related toxicity",
      "normalizedText": "Recovered from radiotherapy-related toxicity",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_2_3a",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 59
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "treatment with herbal medications that have known antitumor activity > 28 days prior to \nrandomization.\n2. Subject has received radiotherapy for locally advanced unresectable or metastatic gastric or \nGEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocor...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "3a"
    },
    {
      "atomicId": "A0060",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "atomicText": "Received systemic immunosuppressive therapy",
      "normalizedText": "Received systemic immunosuppressive therapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_3_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 60
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "systemic_immunosuppression",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0061",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "atomicText": "Received systemic corticosteroids",
      "normalizedText": "Received systemic corticosteroids",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_3_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 61
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "systemic_immunosuppression",
      "expressionNodeId": "1a2"
    },
    {
      "atomicId": "A0062",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "atomicText": "Received hydrocortisone at a physiologic replacement dose up to 30 mg/day",
      "normalizedText": "Received hydrocortisone at a physiologic replacement dose up to 30 mg/day",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 30"
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_3_2a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 62
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "physiologic_steroid_dose",
      "expressionNodeId": "2a1"
    },
    {
      "atomicId": "A0063",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "atomicText": "Received prednisone at a physiologic replacement dose up to 10 mg/day",
      "normalizedText": "Received prednisone at a physiologic replacement dose up to 10 mg/day",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 10"
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_3_2a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 63
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "physiologic_steroid_dose",
      "expressionNodeId": "2a2"
    },
    {
      "atomicId": "A0064",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "atomicText": "Received a single dose of systemic corticosteroids",
      "normalizedText": "Received a single dose of systemic corticosteroids",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_3_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 64
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0065",
      "originalCriterionId": "EXC_3",
      "criterionType": "exclusion",
      "atomicText": "Received systemic corticosteroids as premedication for radiologic imaging contrast use",
      "normalizedText": "Received systemic corticosteroids as premedication for radiologic imaging contrast use",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_3_2c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 65
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "GEJ adenocarcinoma \u2264 14 days prior to randomization and has not recovered from any related \ntoxicity. \n3. Subject has received systemic immunosuppressive therapy, including systemic corticosteroids \nwithin 14 days prior to randomization. Subjects using a physiologic replacement dose of \nhydrocortisone or its equivalent (defined as up to 30 mg per day of hydrocortisone or up to 10 \nmg per day of prednisone), receiving a single dose of systemic corticosteroids or receiving \nsystemic corticoster...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2c"
    },
    {
      "atomicId": "A0066",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "Received other investigational agents",
      "normalizedText": "Received other investigational agents",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600058216
        ],
        "conceptNames": [
          "Other Investigational Agent"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C156875"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C156875",
            "display": "Other Investigational Agent"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_4_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 66
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.\n4. Subject has received other investigational agents or devices within 28 days prior to \nrandomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "investigational_product_exposure",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0067",
      "originalCriterionId": "EXC_4",
      "criterionType": "exclusion",
      "atomicText": "Received other investigational devices",
      "normalizedText": "Received other investigational devices",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "device_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM device_exposure de\nWHERE de.device_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_4_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 67
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "systemic corticosteroids as premedication for radiologic imaging contrast use are allowed.\n4. Subject has received other investigational agents or devices within 28 days prior to \nrandomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "investigational_product_exposure",
      "expressionNodeId": "1a2"
    },
    {
      "atomicId": "A0068",
      "originalCriterionId": "EXC_5",
      "criterionType": "exclusion",
      "atomicText": "Prior severe allergic reaction or intolerance to known ingredients of zolbetuximab",
      "normalizedText": "Prior severe allergic reaction or intolerance to known ingredients of zolbetuximab",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 68
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "zolbetuximab_hypersensitivity",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0069",
      "originalCriterionId": "EXC_5",
      "criterionType": "exclusion",
      "atomicText": "Prior severe allergic reaction or intolerance to other monoclonal antibodies",
      "normalizedText": "Prior severe allergic reaction or intolerance to other monoclonal antibodies",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 69
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mab_hypersensitivity",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0070",
      "originalCriterionId": "EXC_5",
      "criterionType": "exclusion",
      "atomicText": "Prior severe allergic reaction or intolerance to humanized antibodies",
      "normalizedText": "Prior severe allergic reaction or intolerance to humanized antibodies",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5_3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 70
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mab_hypersensitivity",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0071",
      "originalCriterionId": "EXC_5",
      "criterionType": "exclusion",
      "atomicText": "Prior severe allergic reaction or intolerance to chimeric antibodies",
      "normalizedText": "Prior severe allergic reaction or intolerance to chimeric antibodies",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5_4",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 71
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "randomization.\nMedical History or Concurrent Disease\n5. Subject has prior severe allergic reaction or intolerance to known ingredients of zolbetuximab \nor other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mab_hypersensitivity",
      "expressionNodeId": "4"
    },
    {
      "atomicId": "A0072",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Known immediate hypersensitivity to any component of study treatment",
      "normalizedText": "Known immediate hypersensitivity to any component of study treatment",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_6_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 72
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0073",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Known delayed hypersensitivity to any component of study treatment",
      "normalizedText": "Known delayed hypersensitivity to any component of study treatment",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_6_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 73
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0074",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Known intolerance to any component of study treatment",
      "normalizedText": "Known intolerance to any component of study treatment",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_6_3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 74
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0075",
      "originalCriterionId": "EXC_6",
      "criterionType": "exclusion",
      "atomicText": "Known contraindication to any component of study treatment",
      "normalizedText": "Known contraindication to any component of study treatment",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_6_4",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 75
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "or other monoclonal antibodies, including humanized or chimeric antibodies.\n6. Subject has known immediate or delayed hypersensitivity, intolerance or contraindication to \nany component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "drug_allergy_intolerance_contraindication",
      "expressionNodeId": "4"
    },
    {
      "atomicId": "A0076",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Prior severe allergic reaction to Leucovorin",
      "normalizedText": "Prior severe allergic reaction to Leucovorin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_7_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 76
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mfolfox6_leucovorin_contraindication",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0077",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Prior severe allergic reaction to Fluorouracil",
      "normalizedText": "Prior severe allergic reaction to Fluorouracil",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_7_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 77
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mfolfox6_fluorouracil_contraindication",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0078",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Prior severe allergic reaction to Oxaliplatin",
      "normalizedText": "Prior severe allergic reaction to Oxaliplatin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4273629
        ],
        "conceptNames": [
          "Chemotherapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "367336001"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "367336001",
            "display": "Chemotherapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|367336001",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_7_1c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 78
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mfolfox6_oxaliplatin_contraindication",
      "expressionNodeId": "1c"
    },
    {
      "atomicId": "A0079",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Prior intolerance to Leucovorin",
      "normalizedText": "Prior intolerance to Leucovorin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_7_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 79
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mfolfox6_leucovorin_contraindication",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0080",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Prior intolerance to Fluorouracil",
      "normalizedText": "Prior intolerance to Fluorouracil",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_7_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 80
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mfolfox6_fluorouracil_contraindication",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0081",
      "originalCriterionId": "EXC_7",
      "criterionType": "exclusion",
      "atomicText": "Prior intolerance to Oxaliplatin",
      "normalizedText": "Prior intolerance to Oxaliplatin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4273629
        ],
        "conceptNames": [
          "Chemotherapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "367336001"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4273629)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "367336001",
            "display": "Chemotherapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|367336001",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_7_2c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 81
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "any component of study treatment.\n7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "mfolfox6_oxaliplatin_contraindication",
      "expressionNodeId": "2c"
    },
    {
      "atomicId": "A0082",
      "originalCriterionId": "EXC_8",
      "criterionType": "exclusion",
      "atomicText": "Known dihydropyrimidine dehydrogenase (DPD) deficiency",
      "normalizedText": "Known dihydropyrimidine dehydrogenase (DPD) deficiency",
      "category": "biomarker",
      "funnelImpact": {
        "eliminationRate": 2.0,
        "impactScore": 0.02,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_8_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 82
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "7. Subject has prior severe allergic reaction or intolerance to any component of mFOLFOX6.\n8. Subject has known dihydropyrimidine dehydrogenase deficiency (DPD). (NOTE: Screening \nfor DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0083",
      "originalCriterionId": "EXC_9",
      "criterionType": "exclusion",
      "atomicText": "Complete gastric outlet syndrome",
      "normalizedText": "Complete gastric outlet syndrome",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_9_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 83
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "for DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_outlet_syndrome",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0084",
      "originalCriterionId": "EXC_9",
      "criterionType": "exclusion",
      "atomicText": "Partial gastric outlet syndrome",
      "normalizedText": "Partial gastric outlet syndrome",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_9_2a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 84
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "for DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_outlet_syndrome",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0085",
      "originalCriterionId": "EXC_9",
      "criterionType": "exclusion",
      "atomicText": "Persistent or recurrent vomiting",
      "normalizedText": "Persistent or recurrent vomiting",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_9_2b",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 85
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "for DPD deficiency should be conducted per local requirements.)\n9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0086",
      "originalCriterionId": "EXC_10",
      "criterionType": "exclusion",
      "atomicText": "Significant gastric bleeding",
      "normalizedText": "Significant gastric bleeding",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_10_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 86
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted p...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0087",
      "originalCriterionId": "EXC_10",
      "criterionType": "exclusion",
      "atomicText": "Untreated gastric ulcers",
      "normalizedText": "Untreated gastric ulcers",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_10_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 87
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "9. Subject has a complete gastric outlet syndrome or a partial gastric outlet syndrome with \npersistent/recurrent vomiting.\n10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted p...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0088",
      "originalCriterionId": "EXC_11",
      "criterionType": "exclusion",
      "atomicText": "History of positive test for Human Immunodeficiency Virus (HIV) infection",
      "normalizedText": "History of positive test for Human Immunodeficiency Virus (HIV) infection",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          439727
        ],
        "conceptNames": [
          "Human immunodeficiency virus infection"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "86406008"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439727)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "86406008",
            "display": "Human immunodeficiency virus infection"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B20",
            "display": "Human immunodeficiency virus [HIV] disease"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|86406008,B20",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_11_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 88
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted per local requirements. \na. For subjects who are negative for HBs Ag, but HBc Ab positive, an HB DNA test will \nbe performed ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "viral_infection_exclusion",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0089",
      "originalCriterionId": "EXC_11",
      "criterionType": "exclusion",
      "atomicText": "Active Hepatitis B infection (positive HBsAg)",
      "normalizedText": "Active Hepatitis B infection (positive HBsAg)",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          439674
        ],
        "conceptNames": [
          "Chronic viral hepatitis B without delta-agent"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "186639003"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439674)",
        "sqlExecutable": true,
        "valueConstraint": "positive Hepatitis B surface antigen (HBsAg) result"
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "186639003",
            "display": "Chronic viral hepatitis B without delta-agent"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B18.1",
            "display": "Chronic viral hepatitis B without delta-agent"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|186639003,B18.1",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_11_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 89
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted per local requirements. \na. For subjects who are negative for HBs Ag, but HBc Ab positive, an HB DNA test will \nbe performed ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "viral_infection_exclusion",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0090",
      "originalCriterionId": "EXC_11",
      "criterionType": "exclusion",
      "atomicText": "Active Hepatitis C infection",
      "normalizedText": "Active Hepatitis C infection",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          198964
        ],
        "conceptNames": [
          "Chronic hepatitis C"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "128302006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (198964)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "128302006",
            "display": "Chronic viral hepatitis C"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B18.2",
            "display": "Chronic viral hepatitis C"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|128302006,B18.2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_11_3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 90
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "10. Per investigator judgement, subject has significant gastric bleeding and/or untreated gastric \nulcers that exclude the subject from participation.\n11. Subject has a known history of a positive test for human immunodeficiency virus (HIV) \ninfection or known active hepatitis B (positive HBs Ag) or C infection. NOTE: Screening for \nthese infections should be conducted per local requirements. \na. For subjects who are negative for HBs Ag, but HBc Ab positive, an HB DNA test will \nbe performed ...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "viral_infection_exclusion",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0091",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "Active autoimmune disease",
      "normalizedText": "Active autoimmune disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          434621
        ],
        "conceptNames": [
          "Autoimmune disease"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "85828009"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (434621)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "85828009",
            "display": "Autoimmune disease"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|85828009",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 91
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "c. Subjects treated with HCV with undetectable viral load results are eligible.\n12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0092",
      "originalCriterionId": "EXC_12",
      "criterionType": "exclusion",
      "atomicText": "Required systemic treatment for autoimmune disease",
      "normalizedText": "Required systemic treatment for autoimmune disease",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_12_2a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 92
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "c. Subjects treated with HCV with undetectable viral load results are eligible.\n12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0093",
      "originalCriterionId": "EXC_13",
      "criterionType": "exclusion",
      "atomicText": "Active infection",
      "normalizedText": "Active infection",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          432250
        ],
        "conceptNames": [
          "Infectious disease"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "40733004"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (432250)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "40733004",
            "display": "Infectious disease"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|40733004",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_13_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 93
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0094",
      "originalCriterionId": "EXC_13",
      "criterionType": "exclusion",
      "atomicText": "Requires systemic therapy for infection",
      "normalizedText": "Requires systemic therapy for infection",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_13_2",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 94
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0095",
      "originalCriterionId": "EXC_13",
      "criterionType": "exclusion",
      "atomicText": "Infection has completely resolved",
      "normalizedText": "Infection has completely resolved",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 15.0,
        "impactScore": 0.15,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_13_3a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 95
      },
      "provenance": {
        "pageNumber": 26,
        "textSnippet": "12. Subject has an active autoimmune disease that has required systemic treatment within the past \n3 months prior to randomization.\n13. Subject has active infection requiring systemic therapy that has not completely resolved within \n7 days prior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "3a1"
    },
    {
      "atomicId": "A0096",
      "originalCriterionId": "EXC_14",
      "criterionType": "exclusion",
      "atomicText": "Significant cardiovascular disease",
      "normalizedText": "Significant cardiovascular disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_14_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 96
      },
      "provenance": {
        "pageNumber": 65,
        "textSnippet": "13. Subject has active infection requiring systemic therapy that has not completely \nresolved within 7 days prior to randomization.\n14. Subject has significant cardiovascular disease, including any of the following:",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "significant_cardiovascular_disease",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0097",
      "originalCriterionId": "EXC_15",
      "criterionType": "exclusion",
      "atomicText": "History of gastric cancer",
      "normalizedText": "History of gastric cancer",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          196044
        ],
        "conceptNames": [
          "Primary malignant neoplasm of stomach"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "372014001"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (196044)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "372014001",
            "display": "Primary malignant neoplasm of stomach"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C16.9",
            "display": "Malignant neoplasm of stomach, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|372014001,C16.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_15_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 97
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_gej_cancer",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0098",
      "originalCriterionId": "EXC_15",
      "criterionType": "exclusion",
      "atomicText": "History of gastroesophageal junction (GEJ) cancer",
      "normalizedText": "History of gastroesophageal junction (GEJ) cancer",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_15_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 98
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gastric_gej_cancer",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0099",
      "originalCriterionId": "EXC_15",
      "criterionType": "exclusion",
      "atomicText": "History of central nervous system metastases",
      "normalizedText": "History of central nervous system metastases",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_15_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 99
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "cns_involvement",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0100",
      "originalCriterionId": "EXC_15",
      "criterionType": "exclusion",
      "atomicText": "History of carcinomatous meningitis",
      "normalizedText": "History of carcinomatous meningitis",
      "category": "disease_indication",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600131150
        ],
        "conceptNames": [
          "Meningeal Carcinomatosis"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C27383"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 600131150",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://ncithesaurus-stage.nci.nih.gov",
            "code": "C27383",
            "display": "Meningeal Carcinomatosis"
          }
        ],
        "searchParams": "code=http://ncithesaurus-stage.nci.nih.gov|C27383",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_15_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 100
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "e. Cardiac arrhythmias requiring anti-arrhythmic medications (Subject with rate \ncontrolled atrial fibrillation for > 1 month prior to randomization are eligible).\n15. Subject has history of central nervous system metastases and/or carcinomatous \nmeningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "cns_involvement",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0101",
      "originalCriterionId": "EXC_16",
      "criterionType": "exclusion",
      "atomicText": "Peripheral sensory neuropathy grade > 1",
      "normalizedText": "Peripheral sensory neuropathy grade > 1",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4117779
        ],
        "conceptNames": [
          "Peripheral nerve disease"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "302226006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4117779)",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number > 1"
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "302226006",
            "display": "Peripheral nerve disease"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G62.9",
            "display": "Polyneuropathy, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|302226006,G62.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_16_1",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 101
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "meningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "peripheral_neuropathy",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0102",
      "originalCriterionId": "EXC_16",
      "criterionType": "exclusion",
      "atomicText": "Deep tendon reflexes present",
      "normalizedText": "Deep tendon reflexes present",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_16_2a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 102
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "meningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2a1"
    },
    {
      "atomicId": "A0103",
      "originalCriterionId": "EXC_16",
      "criterionType": "exclusion",
      "atomicText": "Other neurological abnormality present",
      "normalizedText": "Other neurological abnormality present",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_16_2b1",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 103
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "meningitis from gastric/GEJ cancer. \n16. Subject has known peripheral sensory neuropathy > grade 1 unless the absence of \ndeep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2b1"
    },
    {
      "atomicId": "A0104",
      "originalCriterionId": "EXC_17",
      "criterionType": "exclusion",
      "atomicText": "Had a major surgical procedure",
      "normalizedText": "Had a major surgical procedure",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_17_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 104
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "deep tendon reflexes is the sole neurological abnormality. \n17. Subject has had a major surgical procedure \uf0a3 28 days prior to randomization. \na. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0105",
      "originalCriterionId": "EXC_18",
      "criterionType": "exclusion",
      "atomicText": "Psychiatric illness that would preclude study compliance per investigator judgment",
      "normalizedText": "Psychiatric illness that would preclude study compliance per investigator judgment",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_18_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 105
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "a. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0106",
      "originalCriterionId": "EXC_18",
      "criterionType": "exclusion",
      "atomicText": "Social situations that would preclude study compliance per investigator judgment",
      "normalizedText": "Social situations that would preclude study compliance per investigator judgment",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_18_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 106
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "a. Subject is without complete recovery from a major surgical procedure \uf0a3 14 days \nprior to randomization.\n18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0107",
      "originalCriterionId": "EXC_19",
      "criterionType": "exclusion",
      "atomicText": "Another malignancy for which treatment is required",
      "normalizedText": "Another malignancy for which treatment is required",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600055953
        ],
        "conceptNames": [
          "Prior Invasive Malignancy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C154619"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C154619",
            "display": "Prior Invasive Malignancy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_19_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 107
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "18. Subject has psychiatric illness or social situations that would preclude study \ncompliance, per investigator judgment.\n19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0108",
      "originalCriterionId": "EXC_20",
      "criterionType": "exclusion",
      "atomicText": "Concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study",
      "normalizedText": "Concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_20_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 108
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0109",
      "originalCriterionId": "EXC_20",
      "criterionType": "exclusion",
      "atomicText": "Concurrent disease, infection or comorbid condition that places the subject at undue risk",
      "normalizedText": "Concurrent disease, infection or comorbid condition that places the subject at undue risk",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_20_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 109
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0110",
      "originalCriterionId": "EXC_20",
      "criterionType": "exclusion",
      "atomicText": "Concurrent disease, infection or comorbid condition that complicates the interpretation of data",
      "normalizedText": "Concurrent disease, infection or comorbid condition that complicates the interpretation of data",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_20_3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 110
      },
      "provenance": {
        "pageNumber": 66,
        "textSnippet": "19. Subject has another malignancy for which treatment is required per investigator\u2019s \nclinical judgment. \n20. Subject has any concurrent disease, infection or comorbid condition that interferes \nwith the ability of the subject to participate in the study, which places the subject at \nundue risk or complicates the interpretation of data in the opinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "3"
    }
  ],
  "logicalGroups": [
    {
      "groupId": "G_INC_3_root",
      "groupLabel": "Criterion INC_3 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0003"
      ]
    },
    {
      "groupId": "G_INC_4_1a",
      "groupLabel": "Criterion INC_4 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0004"
      ]
    },
    {
      "groupId": "G_INC_4_1b",
      "groupLabel": "Criterion INC_4 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0005",
        "A0006"
      ]
    },
    {
      "groupId": "G_INC_4_1",
      "groupLabel": "Criterion INC_4 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0004",
        "A0005",
        "A0006"
      ]
    },
    {
      "groupId": "G_INC_4_root",
      "groupLabel": "Criterion INC_4 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0004",
        "A0005",
        "A0006",
        "A0007"
      ]
    },
    {
      "groupId": "G_INC_5_root",
      "groupLabel": "Criterion INC_5 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0008",
        "A0009"
      ]
    },
    {
      "groupId": "G_INC_6_2a",
      "groupLabel": "Criterion INC_6 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0011",
        "A0012",
        "A0013"
      ]
    },
    {
      "groupId": "G_INC_6_2",
      "groupLabel": "Criterion INC_6 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0011",
        "A0012",
        "A0013"
      ]
    },
    {
      "groupId": "G_INC_6_root",
      "groupLabel": "Criterion INC_6 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0010",
        "A0011",
        "A0012",
        "A0013"
      ]
    },
    {
      "groupId": "G_INC_7_1",
      "groupLabel": "Criterion INC_7 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0014",
        "A0015",
        "A0016"
      ]
    },
    {
      "groupId": "G_INC_7_root",
      "groupLabel": "Criterion INC_7 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0014",
        "A0015",
        "A0016",
        "A0017"
      ]
    },
    {
      "groupId": "G_INC_8_2",
      "groupLabel": "Criterion INC_8 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0019"
      ]
    },
    {
      "groupId": "G_INC_8_root",
      "groupLabel": "Criterion INC_8 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0018",
        "A0019"
      ]
    },
    {
      "groupId": "G_INC_9_1b",
      "groupLabel": "Criterion INC_9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0021",
        "A0022"
      ]
    },
    {
      "groupId": "G_INC_9_1",
      "groupLabel": "Criterion INC_9 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0020",
        "A0021",
        "A0022"
      ]
    },
    {
      "groupId": "G_INC_9_2",
      "groupLabel": "Criterion INC_9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0023",
        "A0024"
      ]
    },
    {
      "groupId": "G_INC_9_root",
      "groupLabel": "Criterion INC_9 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0020",
        "A0021",
        "A0022",
        "A0023",
        "A0024"
      ]
    },
    {
      "groupId": "G_INC_10_2",
      "groupLabel": "Criterion INC_10 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0026",
        "A0027"
      ]
    },
    {
      "groupId": "G_INC_10_root",
      "groupLabel": "Criterion INC_10 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0025",
        "A0026",
        "A0027"
      ]
    },
    {
      "groupId": "G_INC_11_1a2",
      "groupLabel": "Criterion INC_11 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0029",
        "A0030"
      ]
    },
    {
      "groupId": "G_INC_11_1a",
      "groupLabel": "Criterion INC_11 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0028",
        "A0029",
        "A0030"
      ]
    },
    {
      "groupId": "G_INC_12_2_condition",
      "groupLabel": "Criterion INC_12 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0032",
        "A0033"
      ]
    },
    {
      "groupId": "G_INC_12_2_requirement",
      "groupLabel": "Criterion INC_12 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0034",
        "A0035"
      ]
    },
    {
      "groupId": "G_INC_12_2",
      "groupLabel": "Criterion INC_12 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0032",
        "A0033",
        "A0034",
        "A0035"
      ]
    },
    {
      "groupId": "G_INC_12_root",
      "groupLabel": "Criterion INC_12 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0031",
        "A0032",
        "A0033",
        "A0034",
        "A0035"
      ]
    },
    {
      "groupId": "G_INC_13_root",
      "groupLabel": "Criterion INC_13 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0036",
        "A0037",
        "A0038",
        "A0039"
      ]
    },
    {
      "groupId": "G_INC_14_2",
      "groupLabel": "Criterion INC_14 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0041",
        "A0042"
      ]
    },
    {
      "groupId": "G_INC_14_root",
      "groupLabel": "Criterion INC_14 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0040",
        "A0041",
        "A0042",
        "A0043"
      ]
    },
    {
      "groupId": "G_EXC_1_2a",
      "groupLabel": "Criterion EXC_1 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0048",
        "A0049",
        "A0050"
      ]
    },
    {
      "groupId": "G_EXC_1_2b",
      "groupLabel": "Criterion EXC_1 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0051"
      ]
    },
    {
      "groupId": "G_EXC_1_2",
      "groupLabel": "Criterion EXC_1 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0048",
        "A0049",
        "A0050",
        "A0051"
      ]
    },
    {
      "groupId": "G_EXC_1_3b",
      "groupLabel": "Criterion EXC_1 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0053"
      ]
    },
    {
      "groupId": "G_EXC_1_3",
      "groupLabel": "Criterion EXC_1 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0052",
        "A0053"
      ]
    },
    {
      "groupId": "G_EXC_1_root",
      "groupLabel": "Criterion EXC_1 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0047",
        "A0048",
        "A0049",
        "A0050",
        "A0051",
        "A0052",
        "A0053"
      ]
    },
    {
      "groupId": "G_EXC_2_2a",
      "groupLabel": "Criterion EXC_2 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0055",
        "A0056"
      ]
    },
    {
      "groupId": "G_EXC_2_2b",
      "groupLabel": "Criterion EXC_2 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0057",
        "A0058"
      ]
    },
    {
      "groupId": "G_EXC_2_3",
      "groupLabel": "Criterion EXC_2 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0059"
      ]
    },
    {
      "groupId": "G_EXC_2_root",
      "groupLabel": "Criterion EXC_2 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0054",
        "A0055",
        "A0056",
        "A0057",
        "A0058",
        "A0059"
      ]
    },
    {
      "groupId": "G_EXC_3_1a",
      "groupLabel": "Criterion EXC_3 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0060",
        "A0061"
      ]
    },
    {
      "groupId": "G_EXC_3_2",
      "groupLabel": "Criterion EXC_3 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0062",
        "A0063",
        "A0064",
        "A0065"
      ]
    },
    {
      "groupId": "G_EXC_3_root",
      "groupLabel": "Criterion EXC_3 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0060",
        "A0061",
        "A0062",
        "A0063",
        "A0064",
        "A0065"
      ]
    },
    {
      "groupId": "G_EXC_4_1a",
      "groupLabel": "Criterion EXC_4 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0066",
        "A0067"
      ]
    },
    {
      "groupId": "G_EXC_5_root",
      "groupLabel": "Criterion EXC_5 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0068",
        "A0069",
        "A0070",
        "A0071"
      ]
    },
    {
      "groupId": "G_EXC_6_root",
      "groupLabel": "Criterion EXC_6 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0072",
        "A0073",
        "A0074",
        "A0075"
      ]
    },
    {
      "groupId": "G_EXC_7_root",
      "groupLabel": "Criterion EXC_7 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0076",
        "A0077",
        "A0078",
        "A0079",
        "A0080",
        "A0081"
      ]
    },
    {
      "groupId": "G_EXC_9_2",
      "groupLabel": "Criterion EXC_9 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0084",
        "A0085"
      ]
    },
    {
      "groupId": "G_EXC_9_root",
      "groupLabel": "Criterion EXC_9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0083",
        "A0084",
        "A0085"
      ]
    },
    {
      "groupId": "G_EXC_10_root",
      "groupLabel": "Criterion EXC_10 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0086",
        "A0087"
      ]
    },
    {
      "groupId": "G_EXC_11_root",
      "groupLabel": "Criterion EXC_11 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0088",
        "A0089",
        "A0090"
      ]
    },
    {
      "groupId": "G_EXC_12_root",
      "groupLabel": "Criterion EXC_12 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0091",
        "A0092"
      ]
    },
    {
      "groupId": "G_EXC_13_3a",
      "groupLabel": "Criterion EXC_13 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0095"
      ]
    },
    {
      "groupId": "G_EXC_13_root",
      "groupLabel": "Criterion EXC_13 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0093",
        "A0094",
        "A0095"
      ]
    },
    {
      "groupId": "G_EXC_15_1",
      "groupLabel": "Criterion EXC_15 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0097",
        "A0098"
      ]
    },
    {
      "groupId": "G_EXC_15_2",
      "groupLabel": "Criterion EXC_15 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0099",
        "A0100"
      ]
    },
    {
      "groupId": "G_EXC_15_root",
      "groupLabel": "Criterion EXC_15 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0097",
        "A0098",
        "A0099",
        "A0100"
      ]
    },
    {
      "groupId": "G_EXC_16_2a",
      "groupLabel": "Criterion EXC_16 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0102"
      ]
    },
    {
      "groupId": "G_EXC_16_2b",
      "groupLabel": "Criterion EXC_16 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0103"
      ]
    },
    {
      "groupId": "G_EXC_16_2",
      "groupLabel": "Criterion EXC_16 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0102",
        "A0103"
      ]
    },
    {
      "groupId": "G_EXC_16_root",
      "groupLabel": "Criterion EXC_16 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0101",
        "A0102",
        "A0103"
      ]
    },
    {
      "groupId": "G_EXC_18_root",
      "groupLabel": "Criterion EXC_18 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0105",
        "A0106"
      ]
    },
    {
      "groupId": "G_EXC_20_root",
      "groupLabel": "Criterion EXC_20 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0108",
        "A0109",
        "A0110"
      ]
    }
  ],
  "expressionTree": {
    "criteria": {
      "INC_1": {
        "criterionId": "INC_1",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "BEFORE",
            "anchor": "any study-related procedures"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "IRB/IEC approved written informed consent and privacy language obtained from subject or legally authorized representative",
            "omopTable": "observation",
            "strategy": "This is a procedural requirement to ensure ethical and legal standards are met before a patient participates in a study. It is verified by site staff and documentation review, not through standard EHR data queries.",
            "clinicalCategory": "diagnostic_confirmation",
            "queryableStatus": "screening_only"
          }
        }
      },
      "INC_2": {
        "criterionId": "INC_2",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Age >= 18 years at the time of signing informed consent",
          "omopTable": "observation",
          "timeConstraint": "at the time of signing the informed consent",
          "numericConstraintStructured": {
            "value": 18,
            "operator": ">=",
            "unit": "years",
            "parameter": "age"
          },
          "strategy": "Establishes that the subject meets the legal definition of an adult. Age is calculated relative to the date of informed consent. The value of 18 is a common standard but may vary based on local regulations.",
          "clinicalCategory": "demographics",
          "queryableStatus": "fully_queryable"
        }
      },
      "INC_3": {
        "criterionId": "INC_3",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "NOT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "BETWEEN",
                "anchor": "first_dose",
                "anchorEnd": "last_dose"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Participation in another interventional study",
                "omopTable": "observation",
                "timeConstraint": "while on study treatment",
                "timeFrameStructured": {
                  "value": 0,
                  "unit": "",
                  "operator": "between",
                  "relativeEvent": "first_dose"
                },
                "strategy": "Ensures that the study's results are not confounded by other investigational treatments and protects patient safety from potential drug-drug interactions between investigational products.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "requires_manual"
              }
            }
          ]
        }
      },
      "INC_4": {
        "criterionId": "INC_4",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "operator",
                  "operator": "NOT",
                  "operands": [
                    {
                      "nodeId": "1a1",
                      "nodeType": "atomic",
                      "atomicText": "Positive serum pregnancy test",
                      "omopTable": "measurement",
                      "timeConstraint": "at Screening",
                      "timeFrameStructured": {
                        "value": 0,
                        "unit": "",
                        "operator": "during",
                        "relativeEvent": "screening"
                      },
                      "strategy": "Represents an initial negative pregnancy test result, which is logically equivalent to the absence of a positive test.",
                      "clinicalCategory": "demographics",
                      "queryableStatus": "fully_queryable",
                      "clinicalConceptGroup": "pregnancy_status"
                    }
                  ]
                },
                {
                  "nodeId": "1b",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "1b1",
                      "nodeType": "atomic",
                      "atomicText": "Positive serum pregnancy test",
                      "omopTable": "measurement",
                      "timeConstraint": "at Screening",
                      "timeFrameStructured": {
                        "value": 0,
                        "unit": "",
                        "operator": "during",
                        "relativeEvent": "screening"
                      },
                      "strategy": "Represents an initial positive pregnancy test result (elevated serum \u03b2hCG) at the screening visit.",
                      "clinicalCategory": "demographics",
                      "queryableStatus": "fully_queryable",
                      "clinicalConceptGroup": "pregnancy_status"
                    },
                    {
                      "nodeId": "1b2",
                      "nodeType": "atomic",
                      "atomicText": "Demonstrated non-pregnant status through additional testing",
                      "omopTable": "observation",
                      "strategy": "Represents the confirmation of non-pregnant status via subsequent tests (e.g., ultrasound) after an initial positive/elevated \u03b2hCG test.",
                      "clinicalCategory": "demographics",
                      "queryableStatus": "requires_manual",
                      "clinicalConceptGroup": "pregnancy_status"
                    }
                  ]
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "At least one of the other specified conditions applies",
              "omopTable": "observation",
              "strategy": "This is a placeholder representing the second major clause of the eligibility criterion, for which the specific conditions were not provided.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "INC_5": {
        "criterionId": "INC_5",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "1",
            "nodeType": "atomic",
            "atomicText": "Female",
            "omopTable": "person",
            "strategy": "Identifies the population to which the breastfeeding restriction applies.",
            "clinicalCategory": "demographics",
            "queryableStatus": "fully_queryable"
          },
          "requirement": {
            "nodeId": "2",
            "nodeType": "atomic",
            "atomicText": "Agrees not to breastfeed starting at Screening and throughout the study period, and for 6 months after the final study treatment administration",
            "omopTable": "observation",
            "timeConstraint": "The agreement covers the period from Screening until 6 months after the final dose.",
            "strategy": "This ensures infant safety by preventing exposure to the investigational product through breast milk. Compliance is confirmed by reviewing the signed informed consent form.",
            "clinicalCategory": "demographics",
            "queryableStatus": "requires_manual"
          }
        }
      },
      "INC_6": {
        "criterionId": "INC_6",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "1",
            "nodeType": "atomic",
            "atomicText": "Female subject",
            "omopTable": "person",
            "valueConstraint": "gender_concept_id = 8532",
            "strategy": "The requirement to not donate ova applies only to female subjects.",
            "clinicalCategory": "demographics",
            "queryableStatus": "fully_queryable"
          },
          "requirement": {
            "nodeId": "2",
            "nodeType": "operator",
            "operator": "NOT",
            "operands": [
              {
                "nodeId": "2a",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "2a1",
                    "nodeType": "temporal",
                    "temporalConstraint": {
                      "operator": "BETWEEN",
                      "anchor": "Screening",
                      "anchorEnd": "End of study period"
                    },
                    "operand": {
                      "nodeId": "2a1a",
                      "nodeType": "atomic",
                      "atomicText": "Donate ova",
                      "omopTable": "procedure_occurrence",
                      "strategy": "Prohibition on ova donation during the main study period.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "requires_manual",
                      "clinicalConceptGroup": "ova_donation"
                    }
                  },
                  {
                    "nodeId": "2a2",
                    "nodeType": "temporal",
                    "temporalConstraint": {
                      "operator": "AFTER",
                      "anchor": "final administration of oxaliplatin",
                      "value": 9,
                      "unit": "months"
                    },
                    "operand": {
                      "nodeId": "2a2a",
                      "nodeType": "atomic",
                      "atomicText": "Donate ova",
                      "omopTable": "procedure_occurrence",
                      "strategy": "Prohibition on ova donation for a specific period after receiving oxaliplatin.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "requires_manual",
                      "clinicalConceptGroup": "ova_donation"
                    }
                  },
                  {
                    "nodeId": "2a3",
                    "nodeType": "temporal",
                    "temporalConstraint": {
                      "operator": "AFTER",
                      "anchor": "final administration of all other study drugs",
                      "value": 6,
                      "unit": "months"
                    },
                    "operand": {
                      "nodeId": "2a3a",
                      "nodeType": "atomic",
                      "atomicText": "Donate ova",
                      "omopTable": "procedure_occurrence",
                      "strategy": "Prohibition on ova donation for a specific period after receiving any other study drug.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "requires_manual",
                      "clinicalConceptGroup": "ova_donation"
                    }
                  }
                ]
              }
            ]
          }
        }
      },
      "INC_7": {
        "criterionId": "INC_7",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "1",
            "nodeType": "operator",
            "operator": "AND",
            "operands": [
              {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Male subject",
                "omopTable": "person",
                "strategy": "Identifies the subject's sex as male.",
                "clinicalCategory": "demographics",
                "queryableStatus": "fully_queryable"
              },
              {
                "nodeId": "1b",
                "nodeType": "atomic",
                "atomicText": "Sexually active",
                "omopTable": "observation",
                "strategy": "Identifies if the subject is sexually active, a prerequisite for contraception requirements. This is typically self-reported.",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual"
              },
              {
                "nodeId": "1c",
                "nodeType": "atomic",
                "atomicText": "Has female partner(s) of childbearing potential",
                "omopTable": "observation",
                "strategy": "Identifies if the subject's partner(s) are WOCBP, as this determines the risk of pregnancy. This is self-reported information about a non-participant.",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual"
              }
            ]
          },
          "requirement": {
            "nodeId": "2",
            "nodeType": "atomic",
            "atomicText": "Agrees to use a condom during the treatment period and for at least 6 months after the final study drug administration",
            "omopTable": "observation",
            "timeConstraint": "during the treatment period and for at least 6 months after the final study drug administration",
            "strategy": "Confirms and documents the subject's agreement to adhere to protocol-specified contraception methods and duration to prevent potential fetal exposure to the study drug. This is captured during the informed consent process.",
            "clinicalCategory": "safety_exclusion",
            "queryableStatus": "screening_only"
          }
        }
      },
      "INC_8": {
        "criterionId": "INC_8",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "1",
            "nodeType": "atomic",
            "atomicText": "Sex is Male",
            "omopTable": "person",
            "strategy": "This criterion applies only to male subjects.",
            "clinicalCategory": "demographics",
            "queryableStatus": "fully_queryable"
          },
          "requirement": {
            "nodeId": "2",
            "nodeType": "operator",
            "operator": "NOT",
            "operands": [
              {
                "nodeId": "2a",
                "nodeType": "temporal",
                "temporalConstraint": {
                  "operator": "BETWEEN",
                  "anchor": "Screening",
                  "anchorEnd": "6 months after final study drug administration"
                },
                "operand": {
                  "nodeId": "2a1",
                  "nodeType": "atomic",
                  "atomicText": "Sperm donation",
                  "omopTable": "observation",
                  "strategy": "Ensures no risk of conception with sperm potentially affected by the study drug during the study and for a washout period.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                }
              }
            ]
          }
        }
      },
      "INC_9": {
        "criterionId": "INC_9",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "1",
            "nodeType": "operator",
            "operator": "AND",
            "operands": [
              {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Subject is male",
                "omopTable": "person",
                "strategy": "Checks the subject's gender.",
                "clinicalCategory": "demographics",
                "queryableStatus": "fully_queryable"
              },
              {
                "nodeId": "1b",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "1b1",
                    "nodeType": "atomic",
                    "atomicText": "Partner is pregnant",
                    "omopTable": "observation",
                    "strategy": "Patient-reported information about partner's pregnancy status, collected at screening.",
                    "clinicalCategory": "demographics",
                    "queryableStatus": "requires_manual",
                    "clinicalConceptGroup": "partner_status"
                  },
                  {
                    "nodeId": "1b2",
                    "nodeType": "atomic",
                    "atomicText": "Partner is breastfeeding",
                    "omopTable": "observation",
                    "strategy": "Patient-reported information about partner's breastfeeding status, collected at screening.",
                    "clinicalCategory": "demographics",
                    "queryableStatus": "requires_manual",
                    "clinicalConceptGroup": "partner_status"
                  }
                ]
              }
            ]
          },
          "requirement": {
            "nodeId": "2",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "2a",
                "nodeType": "atomic",
                "atomicText": "Agrees to remain abstinent for the required duration",
                "omopTable": "observation",
                "timeConstraint": "Throughout the study period and for 6 months after the final study drug administration",
                "strategy": "Confirmation of agreement documented in the informed consent form.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "screening_only",
                "clinicalConceptGroup": "contraception_agreement"
              },
              {
                "nodeId": "2b",
                "nodeType": "atomic",
                "atomicText": "Agrees to use a condom for the required duration",
                "omopTable": "observation",
                "timeConstraint": "Throughout the study period and for 6 months after the final study drug administration",
                "strategy": "Confirmation of agreement documented in the informed consent form.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "screening_only",
                "clinicalConceptGroup": "contraception_agreement"
              }
            ]
          }
        }
      },
      "INC_10": {
        "criterionId": "INC_10",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Histologically confirmed diagnosis",
              "omopTable": "observation",
              "strategy": "Ensures the diagnosis is confirmed by pathology, which is the gold standard.",
              "clinicalCategory": "diagnostic_confirmation",
              "queryableStatus": "requires_manual"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Gastric adenocarcinoma",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies patients with the primary disease indication of stomach cancer.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "gastric_or_gej_adenocarcinoma"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Gastroesophageal junction (GEJ) adenocarcinoma",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies patients with the primary disease indication of cancer at the gastroesophageal junction.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "gastric_or_gej_adenocarcinoma"
                }
              ]
            }
          ]
        }
      },
      "INC_11": {
        "criterionId": "INC_11",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "randomization",
            "value": 28,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "operator",
            "operator": "AND",
            "operands": [
              {
                "nodeId": "1a1",
                "nodeType": "atomic",
                "atomicText": "Disease is radiologically confirmed",
                "omopTable": "observation",
                "timeConstraint": "within 28 days prior to randomization",
                "timeFrameStructured": {
                  "value": 28,
                  "unit": "days",
                  "operator": "within",
                  "relativeEvent": "randomization"
                },
                "strategy": "Ensures the disease status is based on objective imaging evidence documented in a report.",
                "clinicalCategory": "diagnostic_confirmation",
                "queryableStatus": "requires_manual"
              },
              {
                "nodeId": "1a2",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "1a2a",
                    "nodeType": "atomic",
                    "atomicText": "Locally advanced unresectable disease",
                    "omopTable": "condition_occurrence",
                    "strategy": "Identifies patients with advanced disease that cannot be surgically removed, making them candidates for systemic therapy.",
                    "clinicalCategory": "disease_indication",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "advanced_unresectable_or_metastatic_disease"
                  },
                  {
                    "nodeId": "1a2b",
                    "nodeType": "atomic",
                    "atomicText": "Metastatic disease",
                    "omopTable": "condition_occurrence",
                    "strategy": "Identifies patients whose cancer has spread to distant parts of the body, a key indication for systemic therapy.",
                    "clinicalCategory": "disease_indication",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "advanced_unresectable_or_metastatic_disease"
                  }
                ]
              }
            ]
          }
        }
      },
      "INC_12": {
        "criterionId": "INC_12",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "randomization",
                "value": 28,
                "unit": "days"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Radiologically evaluable disease (measurable and/or non-measurable disease according to RECIST 1.1), per local assessment",
                "omopTable": "observation",
                "timeConstraint": "\u2264 28 days prior to randomization",
                "timeFrameStructured": {
                  "value": 28,
                  "unit": "days",
                  "operator": "within",
                  "relativeEvent": "randomization"
                },
                "strategy": "Confirm presence of evaluable disease via imaging assessment close to the randomization date.",
                "clinicalCategory": "diagnostic_confirmation",
                "queryableStatus": "requires_manual"
              }
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "IMPLICATION",
              "condition": {
                "nodeId": "2_condition",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "2a",
                    "nodeType": "atomic",
                    "atomicText": "Subject has only 1 evaluable lesion",
                    "omopTable": "observation",
                    "strategy": "Identify subjects with a single site of evaluable disease, who may have had localized therapy.",
                    "clinicalCategory": "disease_indication",
                    "queryableStatus": "requires_manual"
                  },
                  {
                    "nodeId": "2b",
                    "nodeType": "temporal",
                    "temporalConstraint": {
                      "operator": "WITHIN",
                      "anchor": "randomization",
                      "value": 3,
                      "unit": "months"
                    },
                    "operand": {
                      "nodeId": "2b1",
                      "nodeType": "atomic",
                      "atomicText": "History of radiotherapy",
                      "omopTable": "procedure_occurrence",
                      "timeConstraint": "\u2264 3 months before randomization",
                      "timeFrameStructured": {
                        "value": 3,
                        "unit": "months",
                        "operator": "within",
                        "relativeEvent": "randomization"
                      },
                      "strategy": "Identify subjects who received radiotherapy recently, which could affect the interpretation of the single lesion.",
                      "clinicalCategory": "prior_therapy",
                      "queryableStatus": "fully_queryable"
                    }
                  }
                ]
              },
              "requirement": {
                "nodeId": "2_requirement",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "2c",
                    "nodeType": "atomic",
                    "atomicText": "The evaluable lesion is outside the field of prior radiotherapy",
                    "omopTable": "observation",
                    "strategy": "Ensure the single lesion was not the target of the recent radiotherapy, making it evaluable for trial purposes.",
                    "clinicalCategory": "diagnostic_confirmation",
                    "queryableStatus": "requires_manual"
                  },
                  {
                    "nodeId": "2d",
                    "nodeType": "atomic",
                    "atomicText": "The evaluable lesion has documented progression following radiation therapy",
                    "omopTable": "observation",
                    "strategy": "Confirm that if the lesion was irradiated, it has since clearly progressed, making it a valid site of active disease.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "requires_manual"
                  }
                ]
              }
            }
          ]
        }
      },
      "INC_13": {
        "criterionId": "INC_13",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Tumor expresses CLDN18.2",
              "omopTable": "measurement",
              "valueConstraint": "Positive",
              "strategy": "Identifies the required target biomarker (Claudin 18.2) for the therapeutic agent.",
              "clinicalCategory": "biomarker",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "cldn18_2_status"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "CLDN18.2 expression in >= 75% of tumor cells",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 75,
                "operator": ">=",
                "unit": "%",
                "parameter": "CLDN18.2 positive tumor cells"
              },
              "strategy": "Sets the quantitative threshold for the percentage of tumor cells that must express the biomarker.",
              "clinicalCategory": "biomarker",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "cldn18_2_status"
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "CLDN18.2 demonstrates moderate to strong membranous staining",
              "omopTable": "measurement",
              "valueConstraint": "staining intensity in ['moderate', 'strong'] and location is 'membranous'",
              "strategy": "Defines the required qualitative intensity and cellular location of the biomarker staining for eligibility.",
              "clinicalCategory": "biomarker",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "cldn18_2_status"
            },
            {
              "nodeId": "4",
              "nodeType": "atomic",
              "atomicText": "CLDN18.2 status determined by central IHC testing",
              "omopTable": "observation",
              "strategy": "Ensures the reliability and standardization of the biomarker assessment by mandating it be performed by a central laboratory using an Immunohistochemistry (IHC) assay.",
              "clinicalCategory": "diagnostic_confirmation",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "cldn18_2_status"
            }
          ]
        }
      },
      "INC_14": {
        "criterionId": "INC_14",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "HER2-negative tumor status",
              "omopTable": "measurement",
              "valueConstraint": "Result is 'Negative' or equivalent concept for HER2 test",
              "strategy": "Identifies patients whose tumor has been tested and found to be negative for HER2 overexpression or gene amplification.",
              "clinicalCategory": "biomarker",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "her2_status"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Gastric tumor",
                  "omopTable": "condition_occurrence",
                  "strategy": "Confirms the primary disease is gastric cancer.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "primary_tumor_location"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Gastroesophageal junction (GEJ) tumor",
                  "omopTable": "condition_occurrence",
                  "strategy": "Confirms the primary disease is gastroesophageal junction cancer.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "primary_tumor_location"
                }
              ]
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "HER2 status determined on a tumor specimen by local or central testing",
              "omopTable": "observation",
              "strategy": "Ensures the HER2 status is documented from a formal laboratory assessment on an appropriate tissue sample.",
              "clinicalCategory": "diagnostic_confirmation",
              "queryableStatus": "partially_queryable"
            }
          ]
        }
      },
      "INC_15": {
        "criterionId": "INC_15",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "ECOG performance status 0-1",
          "omopTable": "observation",
          "numericRangeStructured": {
            "min": 0,
            "max": 1,
            "unit": "",
            "parameter": "ECOG performance status"
          },
          "strategy": "This assesses the subject's functional capacity and ability to perform daily activities. A score of 0-1 indicates the subject is fully active or restricted in strenuous activity but ambulatory.",
          "clinicalCategory": "performance_status",
          "queryableStatus": "fully_queryable"
        }
      },
      "INC_16": {
        "criterionId": "INC_16",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Predicted life expectancy \u2265 12 weeks in the opinion of the investigator",
          "omopTable": "observation",
          "numericConstraintStructured": {
            "value": 12,
            "operator": ">=",
            "unit": "weeks",
            "parameter": "predicted life expectancy"
          },
          "strategy": "This is a subjective assessment by the investigator to ensure the subject is likely to survive long enough to be evaluated for the trial's endpoints. It is not directly queryable from structured data.",
          "clinicalCategory": "performance_status",
          "queryableStatus": "requires_manual"
        }
      },
      "INC_17": {
        "criterionId": "INC_17",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "randomization",
            "value": 14,
            "unit": "days"
          },
          "operand": {
            "nodeId": "root_a",
            "nodeType": "atomic",
            "atomicText": "Required laboratory tests for eligibility assessment collected",
            "omopTable": "measurement",
            "strategy": "This is a meta-criterion that sets the time window for all subsequent lab-based criteria. It also specifies a procedural rule: if multiple samples were collected in this period, the most recent one with available results must be used for eligibility determination.",
            "clinicalCategory": "diagnostic_confirmation",
            "queryableStatus": "partially_queryable"
          }
        }
      },
      "EXC_1": {
        "criterionId": "EXC_1",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Received prior systemic chemotherapy for locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma",
              "omopTable": "drug_exposure",
              "strategy": "Identifies patients who have received at least one line of systemic chemotherapy for the advanced/metastatic disease setting, establishing them as eligible for a subsequent line of therapy.",
              "clinicalCategory": "prior_therapy",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "IMPLICATION",
              "condition": {
                "nodeId": "2a",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "2a1",
                    "nodeType": "atomic",
                    "atomicText": "Received neo-adjuvant or adjuvant chemotherapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Identifies prior therapy in the curative-intent (neo-adjuvant/adjuvant) setting.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "partially_queryable",
                    "clinicalConceptGroup": "prior_systemic_therapy"
                  },
                  {
                    "nodeId": "2a2",
                    "nodeType": "atomic",
                    "atomicText": "Received immunotherapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Identifies prior immunotherapy.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "prior_systemic_therapy"
                  },
                  {
                    "nodeId": "2a3",
                    "nodeType": "atomic",
                    "atomicText": "Received other systemic anticancer therapies",
                    "omopTable": "drug_exposure",
                    "strategy": "Identifies any other prior systemic treatments not otherwise specified.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "partially_queryable",
                    "clinicalConceptGroup": "prior_systemic_therapy"
                  }
                ]
              },
              "requirement": {
                "nodeId": "2b",
                "nodeType": "operator",
                "operator": "NOT",
                "operands": [
                  {
                    "nodeId": "2b1",
                    "nodeType": "temporal",
                    "temporalConstraint": {
                      "operator": "WITHIN",
                      "anchor": "randomization",
                      "value": 6,
                      "unit": "months"
                    },
                    "operand": {
                      "nodeId": "2b1a",
                      "nodeType": "atomic",
                      "atomicText": "Completion of neo-adjuvant/adjuvant chemotherapy, immunotherapy, or other systemic anticancer therapy",
                      "omopTable": "observation",
                      "strategy": "Ensures a sufficient washout period from prior systemic therapies received in a non-metastatic setting to avoid confounding effects.",
                      "clinicalCategory": "prior_therapy",
                      "queryableStatus": "partially_queryable"
                    }
                  }
                ]
              }
            },
            {
              "nodeId": "3",
              "nodeType": "operator",
              "operator": "IMPLICATION",
              "condition": {
                "nodeId": "3a",
                "nodeType": "atomic",
                "atomicText": "Received treatment with herbal medications that have known antitumor activity",
                "omopTable": "drug_exposure",
                "strategy": "Identifies use of herbal medications with potential anticancer properties.",
                "clinicalCategory": "prior_therapy",
                "queryableStatus": "requires_manual"
              },
              "requirement": {
                "nodeId": "3b",
                "nodeType": "operator",
                "operator": "NOT",
                "operands": [
                  {
                    "nodeId": "3b1",
                    "nodeType": "temporal",
                    "temporalConstraint": {
                      "operator": "WITHIN",
                      "anchor": "randomization",
                      "value": 28,
                      "unit": "days"
                    },
                    "operand": {
                      "nodeId": "3b1a",
                      "nodeType": "atomic",
                      "atomicText": "Completion of treatment with herbal medications with known antitumor activity",
                      "omopTable": "observation",
                      "strategy": "Ensures a sufficient washout period from herbal medications to avoid potential drug interactions or confounding biological effects.",
                      "clinicalCategory": "prior_therapy",
                      "queryableStatus": "requires_manual"
                    }
                  }
                ]
              }
            }
          ]
        }
      },
      "EXC_2": {
        "criterionId": "EXC_2",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "randomization",
                "value": 14,
                "unit": "days"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Received radiotherapy",
                "omopTable": "procedure_occurrence",
                "strategy": "Identifies patients who have undergone radiotherapy. The timeframe is constrained by the parent temporal node.",
                "clinicalCategory": "prior_therapy",
                "queryableStatus": "fully_queryable"
              }
            },
            {
              "nodeId": "2a",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a1",
                  "nodeType": "atomic",
                  "atomicText": "Diagnosis of gastric adenocarcinoma",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies the primary tumor location as gastric cancer.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "gastric_gej_adenocarcinoma"
                },
                {
                  "nodeId": "2a2",
                  "nodeType": "atomic",
                  "atomicText": "Diagnosis of gastroesophageal junction (GEJ) adenocarcinoma",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies the primary tumor location as GEJ cancer.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "gastric_gej_adenocarcinoma"
                }
              ]
            },
            {
              "nodeId": "2b",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2b1",
                  "nodeType": "atomic",
                  "atomicText": "Disease is locally advanced unresectable",
                  "omopTable": "observation",
                  "strategy": "Identifies patients with disease that is advanced but not yet spread to distant sites and cannot be surgically removed.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "disease_stage_unresectable_metastatic"
                },
                {
                  "nodeId": "2b2",
                  "nodeType": "atomic",
                  "atomicText": "Disease is metastatic",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies patients whose cancer has spread to distant parts of the body.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "disease_stage_unresectable_metastatic"
                }
              ]
            },
            {
              "nodeId": "3",
              "nodeType": "operator",
              "operator": "NOT",
              "operands": [
                {
                  "nodeId": "3a",
                  "nodeType": "atomic",
                  "atomicText": "Recovered from radiotherapy-related toxicity",
                  "omopTable": "observation",
                  "strategy": "Identifies the resolution of adverse events related to radiotherapy. The parent NOT operator ensures the patient has not recovered.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                }
              ]
            }
          ]
        }
      },
      "EXC_3": {
        "criterionId": "EXC_3",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "EXCEPT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "randomization",
                "value": 14,
                "unit": "days"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "1a1",
                    "nodeType": "atomic",
                    "atomicText": "Received systemic immunosuppressive therapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Identifies subjects who have received any systemic immunosuppressive agents.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "systemic_immunosuppression"
                  },
                  {
                    "nodeId": "1a2",
                    "nodeType": "atomic",
                    "atomicText": "Received systemic corticosteroids",
                    "omopTable": "drug_exposure",
                    "strategy": "Identifies subjects who have received systemic corticosteroids, which are explicitly included in the exclusion.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "systemic_immunosuppression"
                  }
                ]
              }
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a1",
                  "nodeType": "atomic",
                  "atomicText": "Received hydrocortisone at a physiologic replacement dose up to 30 mg/day",
                  "omopTable": "drug_exposure",
                  "numericConstraintStructured": {
                    "value": 30,
                    "operator": "<=",
                    "unit": "mg/day",
                    "parameter": "hydrocortisone daily dose"
                  },
                  "strategy": "Checks for allowed use of hydrocortisone at a low, physiologic dose.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "physiologic_steroid_dose"
                },
                {
                  "nodeId": "2a2",
                  "nodeType": "atomic",
                  "atomicText": "Received prednisone at a physiologic replacement dose up to 10 mg/day",
                  "omopTable": "drug_exposure",
                  "numericConstraintStructured": {
                    "value": 10,
                    "operator": "<=",
                    "unit": "mg/day",
                    "parameter": "prednisone daily dose"
                  },
                  "strategy": "Checks for allowed use of prednisone (or equivalent) at a low, physiologic dose.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "physiologic_steroid_dose"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Received a single dose of systemic corticosteroids",
                  "omopTable": "drug_exposure",
                  "strategy": "Checks for allowed use of a one-time systemic corticosteroid dose.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "2c",
                  "nodeType": "atomic",
                  "atomicText": "Received systemic corticosteroids as premedication for radiologic imaging contrast use",
                  "omopTable": "drug_exposure",
                  "strategy": "Checks for allowed use of corticosteroids specifically for contrast premedication, which requires linking drug administration to a procedure.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "requires_manual"
                }
              ]
            }
          ]
        }
      },
      "EXC_4": {
        "criterionId": "EXC_4",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "randomization",
            "value": 28,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "1a1",
                "nodeType": "atomic",
                "atomicText": "Received other investigational agents",
                "omopTable": "drug_exposure",
                "strategy": "Checks for exposure to investigational drugs to prevent confounding effects from other trials.",
                "clinicalCategory": "prior_therapy",
                "queryableStatus": "partially_queryable",
                "clinicalConceptGroup": "investigational_product_exposure"
              },
              {
                "nodeId": "1a2",
                "nodeType": "atomic",
                "atomicText": "Received other investigational devices",
                "omopTable": "device_exposure",
                "strategy": "Checks for exposure to investigational devices to prevent confounding effects from other trials.",
                "clinicalCategory": "prior_therapy",
                "queryableStatus": "partially_queryable",
                "clinicalConceptGroup": "investigational_product_exposure"
              }
            ]
          }
        }
      },
      "EXC_5": {
        "criterionId": "EXC_5",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Prior severe allergic reaction or intolerance to known ingredients of zolbetuximab",
              "omopTable": "observation",
              "strategy": "Checks for specific contraindications to the study drug or its components based on documented prior hypersensitivity.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "zolbetuximab_hypersensitivity"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Prior severe allergic reaction or intolerance to other monoclonal antibodies",
              "omopTable": "observation",
              "strategy": "Checks for hypersensitivity to the general class of monoclonal antibodies, which may predict a reaction to zolbetuximab.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mab_hypersensitivity"
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "Prior severe allergic reaction or intolerance to humanized antibodies",
              "omopTable": "observation",
              "strategy": "Checks for hypersensitivity to humanized antibodies, a specific subclass of monoclonal antibodies mentioned for clarity.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mab_hypersensitivity"
            },
            {
              "nodeId": "4",
              "nodeType": "atomic",
              "atomicText": "Prior severe allergic reaction or intolerance to chimeric antibodies",
              "omopTable": "observation",
              "strategy": "Checks for hypersensitivity to chimeric antibodies, another specific subclass of monoclonal antibodies mentioned for clarity.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mab_hypersensitivity"
            }
          ]
        }
      },
      "EXC_6": {
        "criterionId": "EXC_6",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Known immediate hypersensitivity to any component of study treatment",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with a known history of immediate allergic reactions to the study drug or its components to prevent severe adverse events.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "drug_allergy_intolerance_contraindication"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Known delayed hypersensitivity to any component of study treatment",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with a known history of delayed allergic reactions to the study drug or its components to prevent adverse events.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "drug_allergy_intolerance_contraindication"
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "Known intolerance to any component of study treatment",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects who cannot tolerate the study drug due to non-allergic adverse effects, ensuring patient safety and treatment compliance.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "drug_allergy_intolerance_contraindication"
            },
            {
              "nodeId": "4",
              "nodeType": "atomic",
              "atomicText": "Known contraindication to any component of study treatment",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with pre-existing conditions or factors that make administration of the study drug unsafe.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "drug_allergy_intolerance_contraindication"
            }
          ]
        }
      },
      "EXC_7": {
        "criterionId": "EXC_7",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1a",
              "nodeType": "atomic",
              "atomicText": "Prior severe allergic reaction to Leucovorin",
              "omopTable": "condition_occurrence",
              "timeConstraint": "prior",
              "strategy": "Identifies a history of severe allergy to Leucovorin (folinic acid), a component of the mFOLFOX6 regimen.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mfolfox6_leucovorin_contraindication"
            },
            {
              "nodeId": "1b",
              "nodeType": "atomic",
              "atomicText": "Prior severe allergic reaction to Fluorouracil",
              "omopTable": "condition_occurrence",
              "timeConstraint": "prior",
              "strategy": "Identifies a history of severe allergy to Fluorouracil (5-FU), a component of the mFOLFOX6 regimen.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mfolfox6_fluorouracil_contraindication"
            },
            {
              "nodeId": "1c",
              "nodeType": "atomic",
              "atomicText": "Prior severe allergic reaction to Oxaliplatin",
              "omopTable": "condition_occurrence",
              "timeConstraint": "prior",
              "strategy": "Identifies a history of severe allergy to Oxaliplatin, a component of the mFOLFOX6 regimen.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mfolfox6_oxaliplatin_contraindication"
            },
            {
              "nodeId": "2a",
              "nodeType": "atomic",
              "atomicText": "Prior intolerance to Leucovorin",
              "omopTable": "condition_occurrence",
              "timeConstraint": "prior",
              "strategy": "Identifies a history of intolerance to Leucovorin (folinic acid), a component of the mFOLFOX6 regimen.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mfolfox6_leucovorin_contraindication"
            },
            {
              "nodeId": "2b",
              "nodeType": "atomic",
              "atomicText": "Prior intolerance to Fluorouracil",
              "omopTable": "condition_occurrence",
              "timeConstraint": "prior",
              "strategy": "Identifies a history of intolerance to Fluorouracil (5-FU), a component of the mFOLFOX6 regimen.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mfolfox6_fluorouracil_contraindication"
            },
            {
              "nodeId": "2c",
              "nodeType": "atomic",
              "atomicText": "Prior intolerance to Oxaliplatin",
              "omopTable": "condition_occurrence",
              "timeConstraint": "prior",
              "strategy": "Identifies a history of intolerance to Oxaliplatin, a component of the mFOLFOX6 regimen.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "mfolfox6_oxaliplatin_contraindication"
            }
          ]
        }
      },
      "EXC_8": {
        "criterionId": "EXC_8",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Known dihydropyrimidine dehydrogenase (DPD) deficiency",
          "omopTable": "condition_occurrence",
          "strategy": "This is a safety exclusion criterion. DPD deficiency is a genetic condition that can cause severe toxicity with certain chemotherapies (fluoropyrimidines). The note indicates that determination of this status is based on local screening procedures, which could involve genetic testing or enzyme activity assays.",
          "clinicalCategory": "safety_exclusion",
          "queryableStatus": "partially_queryable"
        }
      },
      "EXC_9": {
        "criterionId": "EXC_9",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Complete gastric outlet syndrome",
              "omopTable": "condition_occurrence",
              "strategy": "Identify patients with a diagnosis of complete gastric outlet syndrome.",
              "clinicalCategory": "disease_indication",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "gastric_outlet_syndrome"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "AND",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Partial gastric outlet syndrome",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify patients with a diagnosis of partial gastric outlet syndrome.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "gastric_outlet_syndrome"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Persistent or recurrent vomiting",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify patients with documented persistent or recurrent vomiting, which often requires chart review to confirm the pattern.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "partially_queryable"
                }
              ]
            }
          ]
        }
      },
      "EXC_10": {
        "criterionId": "EXC_10",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Significant gastric bleeding",
              "omopTable": "condition_occurrence",
              "strategy": "This is a subjective assessment by the investigator to determine if any gastric bleeding is clinically significant enough to pose a safety risk for study participation.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Untreated gastric ulcers",
              "omopTable": "condition_occurrence",
              "strategy": "This is a subjective assessment by the investigator to confirm the presence of gastric ulcers and the absence of adequate, current treatment for them.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "EXC_11": {
        "criterionId": "EXC_11",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "History of positive test for Human Immunodeficiency Virus (HIV) infection",
              "omopTable": "condition_occurrence",
              "strategy": "Identify patients with a documented diagnosis of HIV infection or a record of a positive HIV test.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "viral_infection_exclusion"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Active Hepatitis B infection (positive HBsAg)",
              "omopTable": "measurement",
              "valueConstraint": "positive Hepatitis B surface antigen (HBsAg) result",
              "strategy": "Identify patients with a positive lab result for Hepatitis B surface antigen (HBsAg), indicating active infection.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "viral_infection_exclusion"
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "Active Hepatitis C infection",
              "omopTable": "condition_occurrence",
              "strategy": "Identify patients with a documented diagnosis of Hepatitis C infection or a record of a positive test (e.g., HCV RNA).",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "viral_infection_exclusion"
            }
          ]
        }
      },
      "EXC_12": {
        "criterionId": "EXC_12",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Active autoimmune disease",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with an ongoing autoimmune condition. The 'active' status is a clinical judgment and typically requires manual review.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            },
            {
              "nodeId": "2",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "randomization",
                "value": 3,
                "unit": "months"
              },
              "operand": {
                "nodeId": "2a",
                "nodeType": "atomic",
                "atomicText": "Required systemic treatment for autoimmune disease",
                "omopTable": "drug_exposure",
                "timeConstraint": "within the past 3 months prior to randomization",
                "timeFrameStructured": {
                  "value": 3,
                  "unit": "months",
                  "operator": "within",
                  "relativeEvent": "randomization"
                },
                "strategy": "Identifies use of systemic therapies (e.g., corticosteroids, biologics) which indicates the autoimmune disease was severe enough to require treatment recently.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "fully_queryable"
              }
            }
          ]
        }
      },
      "EXC_13": {
        "criterionId": "EXC_13",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Active infection",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies a current diagnosis of an infectious disease.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Requires systemic therapy for infection",
              "omopTable": "drug_exposure",
              "strategy": "Identifies the use of systemic anti-infective medications (e.g., IV antibiotics, oral antivirals), which implies the infection is significant.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "3",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "randomization",
                "value": 7,
                "unit": "days"
              },
              "operand": {
                "nodeId": "3a",
                "nodeType": "operator",
                "operator": "NOT",
                "operands": [
                  {
                    "nodeId": "3a1",
                    "nodeType": "atomic",
                    "atomicText": "Infection has completely resolved",
                    "omopTable": "observation",
                    "strategy": "Checks for the absence of a documented resolution of the infection within the 7-day window prior to randomization. This is typically a clinical assessment found in notes.",
                    "clinicalCategory": "safety_exclusion",
                    "queryableStatus": "requires_manual"
                  }
                ]
              }
            }
          ]
        }
      },
      "EXC_14": {
        "criterionId": "EXC_14",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Significant cardiovascular disease",
          "omopTable": "condition_occurrence",
          "strategy": "This is a general exclusion category for patients with significant cardiovascular risk. The specific conditions that qualify under this category would be listed subsequently and would form an OR group.",
          "clinicalCategory": "safety_exclusion",
          "queryableStatus": "partially_queryable",
          "clinicalConceptGroup": "significant_cardiovascular_disease"
        }
      },
      "EXC_15": {
        "criterionId": "EXC_15",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "atomic",
                  "atomicText": "History of gastric cancer",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies the primary malignancy as gastric cancer. This is required as the origin for the CNS condition.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "gastric_gej_cancer"
                },
                {
                  "nodeId": "1b",
                  "nodeType": "atomic",
                  "atomicText": "History of gastroesophageal junction (GEJ) cancer",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies the primary malignancy as GEJ cancer. This is required as the origin for the CNS condition.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "gastric_gej_cancer"
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "History of central nervous system metastases",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies one of the required types of CNS involvement.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "cns_involvement"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "History of carcinomatous meningitis",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies the second possible type of required CNS involvement.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "cns_involvement"
                }
              ]
            }
          ]
        }
      },
      "EXC_16": {
        "criterionId": "EXC_16",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "EXCEPT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Peripheral sensory neuropathy grade > 1",
              "omopTable": "observation",
              "numericConstraintStructured": {
                "value": 1,
                "operator": ">",
                "unit": "",
                "parameter": "Peripheral sensory neuropathy grade (e.g., CTCAE)"
              },
              "strategy": "Identifies patients with clinically significant peripheral sensory neuropathy.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "peripheral_neuropathy"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "AND",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "operator",
                  "operator": "NOT",
                  "operands": [
                    {
                      "nodeId": "2a1",
                      "nodeType": "atomic",
                      "atomicText": "Deep tendon reflexes present",
                      "omopTable": "observation",
                      "strategy": "This node identifies the presence of DTRs. The parent NOT operator negates it to find subjects with an 'absence of' DTRs.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "requires_manual"
                    }
                  ]
                },
                {
                  "nodeId": "2b",
                  "nodeType": "operator",
                  "operator": "NOT",
                  "operands": [
                    {
                      "nodeId": "2b1",
                      "nodeType": "atomic",
                      "atomicText": "Other neurological abnormality present",
                      "omopTable": "condition_occurrence",
                      "strategy": "This node identifies any other neurological abnormalities. The parent NOT operator negates it, ensuring that the absence of DTRs is the 'sole' finding.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "requires_manual"
                    }
                  ]
                }
              ]
            }
          ]
        }
      },
      "EXC_17": {
        "criterionId": "EXC_17",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "randomization",
            "value": 28,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Had a major surgical procedure",
            "omopTable": "procedure_occurrence",
            "strategy": "This criterion excludes patients who have recently undergone major surgery, as this could confound the assessment of adverse events or affect the patient's ability to tolerate the study treatment. Defining 'major' surgery may require a specific list of procedure codes.",
            "clinicalCategory": "safety_exclusion",
            "queryableStatus": "partially_queryable"
          }
        }
      },
      "EXC_18": {
        "criterionId": "EXC_18",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Psychiatric illness that would preclude study compliance per investigator judgment",
              "omopTable": "condition_occurrence",
              "strategy": "This is a subjective assessment by the investigator to exclude patients whose psychiatric conditions would make it difficult or unsafe for them to adhere to the study protocol.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Social situations that would preclude study compliance per investigator judgment",
              "omopTable": "observation",
              "strategy": "This is a subjective assessment by the investigator to exclude patients whose social circumstances (e.g., unstable housing, lack of support) would prevent them from reliably participating in the study.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "EXC_19": {
        "criterionId": "EXC_19",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Another malignancy for which treatment is required",
          "omopTable": "condition_occurrence",
          "strategy": "This criterion excludes subjects with a concurrent cancer requiring active treatment, as this could confound the assessment of the study treatment's efficacy or safety. The determination of whether treatment is required is based on the investigator's clinical judgment.",
          "clinicalCategory": "safety_exclusion",
          "queryableStatus": "requires_manual"
        }
      },
      "EXC_20": {
        "criterionId": "EXC_20",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Concurrent disease, infection or comorbid condition that interferes with the ability of the subject to participate in the study",
              "omopTable": "observation",
              "strategy": "This is a general safety exclusion based on investigator judgment. It covers any condition that makes study participation physically or logistically difficult or impossible for the subject.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Concurrent disease, infection or comorbid condition that places the subject at undue risk",
              "omopTable": "observation",
              "strategy": "This is a general safety exclusion based on investigator judgment. It covers any condition that would make participation in the study unacceptably dangerous for the subject.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "Concurrent disease, infection or comorbid condition that complicates the interpretation of data",
              "omopTable": "observation",
              "strategy": "This is a general exclusion to protect study integrity, based on investigator judgment. It covers any condition that could act as a confounding factor, making it difficult to attribute outcomes to the study intervention.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      }
    }
  },
  "funnelStages": [
    {
      "stageId": "S1",
      "stageName": "Disease Indication",
      "stageOrder": 1,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0083",
        "A0084",
        "A0085",
        "A0099",
        "A0100"
      ],
      "estimatedEliminationRate": 0.0
    },
    {
      "stageId": "S2",
      "stageName": "Demographics",
      "stageOrder": 2,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0014",
        "A0015",
        "A0016",
        "A0018",
        "A0020",
        "A0021",
        "A0022"
      ],
      "estimatedEliminationRate": 0.0
    },
    {
      "stageId": "S3",
      "stageName": "Biomarker Requirements",
      "stageOrder": 3,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0036",
        "A0037",
        "A0038",
        "A0039",
        "A0040",
        "A0043",
        "A0082"
      ],
      "estimatedEliminationRate": 40.285714285714285
    },
    {
      "stageId": "S4",
      "stageName": "Treatment History",
      "stageOrder": 4,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0047",
        "A0048",
        "A0049",
        "A0050",
        "A0051",
        "A0052",
        "A0053",
        "A0060",
        "A0061",
        "A0062",
        "A0063",
        "A0064",
        "A0065",
        "A0092"
      ],
      "estimatedEliminationRate": 27.5
    },
    {
      "stageId": "S7",
      "stageName": "Safety Exclusions",
      "stageOrder": 7,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0003",
        "A0004",
        "A0005",
        "A0006",
        "A0007",
        "A0008",
        "A0009",
        "A0010",
        "A0011",
        "A0012",
        "A0013",
        "A0017",
        "A0019",
        "A0023",
        "A0024",
        "A0059",
        "A0068",
        "A0069",
        "A0070",
        "A0071",
        "A0072",
        "A0073",
        "A0074",
        "A0075",
        "A0076",
        "A0077",
        "A0078",
        "A0079",
        "A0080",
        "A0081",
        "A0086",
        "A0087",
        "A0088",
        "A0089",
        "A0090",
        "A0091",
        "A0093",
        "A0094",
        "A0095",
        "A0096",
        "A0103",
        "A0104",
        "A0105",
        "A0106",
        "A0107",
        "A0108",
        "A0109",
        "A0110"
      ],
      "estimatedEliminationRate": 11.979166666666666
    }
  ],
  "metadata": {
    "totalAtomics": 110,
    "totalGroups": 61,
    "totalStages": 5,
    "stagesWithQueries": 42,
    "stagesWithFhir": 42
  }
}